Anaptysbio (ANAB) Interest & Investment Income (2016 - 2026)

Anaptysbio's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• Quarterly Interest & Investment Income fell 39.88% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (down 40.18% YoY) and the FY2025 annual result came in at $13.5 million, down 31.8% from the prior year.
• Interest & Investment Income was $2.7 million for Q1 2026 at Anaptysbio, up from $2.5 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $5.3 million in Q3 2024 and bottomed at $342000.0 in Q1 2022.
• A 5-year average of $3.7 million and a median of $4.4 million in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income surged 3434.38% — and 2025, when it sank 52.35%.
• Anaptysbio's Interest & Investment Income stood at $3.8 million in 2022, then advanced by 27.12% to $4.9 million in 2023, then rose by 7.85% to $5.3 million in 2024, then sank by 52.35% to $2.5 million in 2025, then advanced by 5.78% to $2.7 million in 2026.
• Business Quant data shows ANAB's Interest & Investment Income at $2.7 million in Q1 2026, $2.5 million in Q4 2025, and $2.9 million in Q3 2025.